Literature DB >> 29576236

Relation of Resting Heart Rate to Incident Atrial Fibrillation (From ARIC [Atherosclerosis Risk in Communities] Study).

Weijia Wang1, Alvaro Alonso2, Elsayed Z Soliman3, Wesley T O'Neal4, Hugh Calkins5, Lin Yee Chen6, Marie Diener-West1, Moyses Szklo7.   

Abstract

The evidence on the association between resting heart rate (HR) and incident atrial fibrillation (AF) is conflicting. Whether change in resting HR is associated with incident AF is unknown. We evaluated 11,545 participants (mean [±standard deviation] age: 57 ± 5.7 years) free of AF at baseline (1990 to 1992). Resting HR was obtained from 10-second electrocardiograms at baseline and 3 years later. AF diagnosis was ascertained from visit electrocardiograms, hospital discharge records, and death certificates through 2013. High and low resting HR were defined as ≥80 and <55 beats/min, respectively. Increase and decrease in HR were defined as a 3-year HR difference >15 and <-15 beats/min, respectively. Over a median follow-up of 22.5 years, 1,746 (15%) participants developed AF. Both baseline high resting HR and increase in HR were independently associated with incident AF (hazard ratio = 1.2, 95% confidence interval = 1.0 to 1.5 and hazard ratio = 1.4, 95% confidence interval = 1.1 to 1.9). Increase in HR was no longer associated with incident AF after additional adjustment for incident heart failure. In stratified analyses, increase in HR was associated only with AF in participants <60 years, with bachelor's degree or above, without diabetes, and without hypertension (p values for interaction ≤0.05). In conclusion, in a middle-aged population, high resting HR is associated with higher AF risk. Increase in resting HR is also associated with higher AF risk, especially in individuals without traditional AF risk factors. Whether interventions to decrease HR can prevent AF remain to be examined.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29576236     DOI: 10.1016/j.amjcard.2018.01.037

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  How Heart Rate Should Be Controlled in Patients with Atherosclerosis and Heart Failure.

Authors:  Rose Mary Ferreira Lisboa da Silva; Anaisa Silva Roever Borges; Nilson Penha Silva; Elmiro Santos Resende; Gary Tse; Tong Liu; Leonardo Roever; Giuseppe Biondi-Zoccai
Journal:  Curr Atheroscler Rep       Date:  2018-09-17       Impact factor: 5.113

2.  Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium.

Authors:  J E Siland; B Geelhoed; C Roselli; B Wang; H J Lin; S Weiss; S Trompet; M E van den Berg; E Z Soliman; L Y Chen; I Ford; J W Jukema; P W Macfarlane; J Kornej; H Lin; K L Lunetta; M Kavousi; J A Kors; M A Ikram; X Guo; J Yao; M Dörr; S B Felix; U Völker; N Sotoodehnia; D E Arking; B H Stricker; S R Heckbert; S A Lubitz; E J Benjamin; A Alonso; P T Ellinor; P van der Harst; M Rienstra
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.240

3.  Automated risk assessment of newly detected atrial fibrillation poststroke from electronic health record data using machine learning and natural language processing.

Authors:  Sheng-Feng Sung; Kuan-Lin Sung; Ru-Chiou Pan; Pei-Ju Lee; Ya-Han Hu
Journal:  Front Cardiovasc Med       Date:  2022-07-29

4.  Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Miriam A M Nji; Scott D Solomon; Lin Yee Chen; Amil M Shah; Elsayed Z Soliman; Aniqa B Alam; Vinita Subramanya; Alvaro Alonso
Journal:  Int J Cardiol       Date:  2021-07-08       Impact factor: 4.039

5.  Independent effect of physical activity and resting heart rate on the incidence of atrial fibrillation in the general population.

Authors:  Yeon Woo Choi; Minsu Park; Young-Hyo Lim; Jisun Myung; Byung Sik Kim; Yonggu Lee; Jeong-Hun Shin; Hwan-Cheol Park; Jinho Shin; Chun Ki Kim; Jin-Kyu Park
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.